BARD1 and Ewing sarcoma: The interaction of the major oncogenic driver, EWS-FLI1, with the C-terminus of BARD1 as well as a frameshift deletion in the BRCA1-binding region of BARD1 in Ewing sarcoma strongly support the need for more functional studies of impaired DDR in Ewing sarcoma.